Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion type Assertion NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_head.
- NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion description "[These results suggest that PME-CD40L DC are uniquely capable of delivering the complex array of signals needed to generate stable CD28(+) REHA CTL, which if generated in vivo may have significant clinical benefit for the treatment of infectious disease and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_provenance.
- NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion evidence source_evidence_literature NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_provenance.
- NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion SIO_000772 18832685 NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_provenance.
- NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion wasDerivedFrom befree-20150227 NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_provenance.
- NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_assertion wasGeneratedBy ECO_0000203 NP291456.RA-sCu4KT97nsMcCwwpDzYUgrK4NPRAGuLTJZFtSeRFzg130_provenance.